| 1. |
From the Editor |
| |
Inpharma Weekly,
Volume &NA;,
Issue 983,
1995,
Page 2-2
&NA;,
Preview
|
PDF (1117KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 2. |
Three points of attack in fight against restenosis |
| |
Inpharma Weekly,
Volume &NA;,
Issue 983,
1995,
Page 3-4
Gill Higgins,
Preview
|
PDF (2130KB)
|
|
摘要:
The 3 main processes involved in restenosis are currently being addressed by pharmaceutical research. New GPIIb/IIIa receptor antagonists look set to provide serious competition to conventional antiplatelet agents, such as aspirin and ticlopidine, in the prevention of thrombus formation. Agents that directly target neointimal proliferation, and even vascular remodelling, are also at various stages of development. A discussion of these approaches took place at the 44th Annual Scientific Sessions of the American College of Cardiology [New Orleans, US; March 1995].
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 3. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 983,
1995,
Page 5-5
&NA;,
Preview
|
PDF (993KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 4. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 983,
1995,
Page 6-6
&NA;,
Preview
|
PDF (1021KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 5. |
‘Value’ - the third hurdle to drug acceptance |
| |
Inpharma Weekly,
Volume &NA;,
Issue 983,
1995,
Page 7-8
Gill Higgins,
Preview
|
PDF (2193KB)
|
|
摘要:
Having received approval for a drug, companies now need to assess the additional information requirements that exist in the current environment of cost consciousness. Previously, US companies were only concerned with supplying adequate data on efficacy and tolerability to the FDA, but now there is a demand for cost-effectiveness information that can denote the value of a drug to managed care players. Speakers at the FDA-sponsored meeting‘Comparing Treatments: Safety, Effectiveness and Cost Effectiveness’[Bethesda, US; March 1995] discussed these new information requirements, and presented the latest US guidelines on how to conduct relevant studies.
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 6. |
Drug-free, GVHD-free transplantation? |
| |
Inpharma Weekly,
Volume &NA;,
Issue 983,
1995,
Page 8-8
&NA;,
Preview
|
PDF (1080KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 7. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 983,
1995,
Page 9-9
&NA;,
Preview
|
PDF (948KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 8. |
News from the 44th Annual Scientific Sessions of the American College of CardiologyNew Orleans, US March 1995 |
| |
Inpharma Weekly,
Volume &NA;,
Issue 983,
1995,
Page 10-11
&NA;,
Preview
|
PDF (2157KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 9. |
Targeting TNF promising for arthritis |
| |
Inpharma Weekly,
Volume &NA;,
Issue 983,
1995,
Page 12-12
&NA;,
Preview
|
PDF (1088KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 10. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 983,
1995,
Page 13-13
&NA;,
Preview
|
PDF (993KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
首页
